Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
Gerontology|January 31, 2022
Frail Older Adults with Presymptomatic SARS-CoV-2 Infection: Clinical Course and PrognosisYochai Levy, Adi Turjeman, Lisa Cooper, et al.Journal of Clinical Medicine|September 9, 2022
Re-Admission of COVID-19 Patients Hospitalized with Omicron Variant-A Retrospective Cohort StudyIrit Ayalon-Dangur, Adi Turjeman, Bar Basharim, et al.Pituitary|December 8, 2023
Cabergoline treatment for surgery-naïve non-functioning pituitary macroadenomasIrit Ayalon-Dangur, Adi Turjeman, Dania Hirsch, et al.Plos One|August 31, 2021
Risk factors for treatment failure in women with uncomplicated lower urinary tract infectionRomain Martischang, Maciek Godycki-Ćwirko, Anna Kowalczyk, et al.Cell Proliferation|November 10, 2024
Predicting tumour resistance to paclitaxel and carboplatin utilising genome-wide screening in haploid human embryonic stem cellsJonathan Nissenbaum, Emanuel Segal, Hagit Philip, et al.The Journal of Clinical Endocrinology and Metabolism|March 22, 2025
The beneficial effects of sodium-glucose cotransporter 2 inhibitors on anemia in type 2 diabetes-a real world studyTali Steinmetz, Shira Goldman, Kim Ben Tikva Kagan, et al.Eclinicalmedicine|December 9, 2022
Duration of antibiotic treatment for Gram-negative bacteremia - Systematic review and individual participant data (IPD) meta-analysisAdi Turjeman, Elodie von Dach, José Molina, et al.Scientific Reports|March 26, 2021
Risk factors for hospital readmission following complicated urinary tract infectionTanya Babich, Noa Eliakim-Raz, Adi Turjeman, et al.Stem Cell Reports|November 1, 2024
Genome-wide screening reveals essential roles for HOX genes and imprinted genes during caudal neurogenesis of human embryonic stem cellsShay Kinreich, Anna Bialer-Tsypin, Ruth Viner-Breuer, et al.BMJ Open|February 9, 2021
Piperacillin-tazobactam versus meropenem for treatment of bloodstream infections caused by third-generation cephalosporin-resistant Enterobacteriaceae: a study protocol for a non-inferiority open-label randomised controlled trial (PeterPen)Roni Bitterman, Fidi Koppel, Cristina Mussini, et al.Pageof 4